dc.contributor.advisor | Weber, Martin Prof. Dr. | |
dc.contributor.author | Nissimov, Nitzan | |
dc.date.accessioned | 2021-08-10T08:03:52Z | |
dc.date.available | 2021-08-26T00:50:03Z | |
dc.date.issued | 2021-08-10 | |
dc.identifier.uri | http://hdl.handle.net/21.11130/00-1735-0000-0008-58D7-3 | |
dc.identifier.uri | http://dx.doi.org/10.53846/goediss-8779 | |
dc.language.iso | eng | de |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject.ddc | 610 | de |
dc.title | Direct, indirect and longitudinal immunological effects of anti-CD20 mediated B cell depletion in Multiple Sclerosis | de |
dc.type | doctoralThesis | de |
dc.contributor.referee | Lühder, Fred PD Dr. | |
dc.date.examination | 2021-08-19 | |
dc.description.abstracteng | B cell depletion via anti-CD20 antibodies is a highly effective treatment for multiple sclerosis (MS). However, little is known about the maturation/activation stage of the returning B cell population after treatment cessation and the wider effects on other immune cells. In the present study, 15 relapsing-remitting MS patients receiving 1,000 mg of rituximab were included. B, T, and myeloid cells were analyzed before anti-CD20 administration and in different time intervals thereafter over a period of 24 mo. In comparison to the phenotype before anti-CD20 treatment, the reappearing B cell pool revealed a less mature and more activated phenotype: 1) reappearing B cells were significantly enriched in transitional and mature naive phenotypes; 2) the frequency of memory B cells was reduced; and 3) reappearing B cells showed an enhanced expression of activation markers CD25 and CD69, and expressed significantly higher levels of costimulatory CD40 and CD86. T cells showed 1) a persistent increase in naive and 2) a decrease in terminally differentiated subsets. | de |
dc.contributor.coReferee | Wienands, Jürgen Prof. Dr. | |
dc.subject.eng | multiple sclerosis | de |
dc.subject.eng | anti-CD20 therapy | de |
dc.subject.eng | B cells | de |
dc.subject.eng | T cells | de |
dc.subject.eng | repletion | de |
dc.identifier.urn | urn:nbn:de:gbv:7-21.11130/00-1735-0000-0008-58D7-3-7 | |
dc.affiliation.institute | Medizinische Fakultät | de |
dc.subject.gokfull | Medizin (PPN619874732) | de |
dc.subject.gokfull | Neurologie - Allgemein- und Gesamtdarstellungen (PPN619876247) | de |
dc.subject.gokfull | Neuroanatomie, Neurophysiologie, Neuropathologie (PPN619876255) | de |
dc.description.embargoed | 2021-08-26 | |
dc.identifier.ppn | 1766080383 | |